SELLAS Life Sciences Group, Inc. (SLS)
11.74
+0.41
(+3.62%)
USD |
NASDAQ |
Oct 02, 16:00
11.75
+0.01
(+0.09%)
After-Hours: 20:00
SELLAS Life Sciences Group Market Cap : 2.371B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.371B |
| October 01, 2026 | 2.288B |
| September 30, 2026 | 2.486B |
| September 29, 2026 | 2.324B |
| September 28, 2026 | 2.340B |
| September 25, 2026 | 2.344B |
| September 24, 2026 | 2.419B |
| September 23, 2026 | 2.326B |
| September 22, 2026 | 2.427B |
| September 21, 2026 | 2.296B |
| September 18, 2026 | 2.320B |
| September 17, 2026 | 2.328B |
| September 16, 2026 | 2.354B |
| September 15, 2026 | 2.280B |
| September 14, 2026 | 2.367B |
| September 11, 2026 | 2.331B |
| September 10, 2026 | 2.724B |
| September 09, 2026 | 2.817B |
| September 08, 2026 | 2.819B |
| September 04, 2026 | 2.799B |
| September 03, 2026 | 2.766B |
| September 02, 2026 | 2.859B |
| September 01, 2026 | 2.669B |
| August 31, 2026 | 2.694B |
| August 28, 2026 | 2.667B |
| Date | Value |
|---|---|
| August 27, 2026 | 3.071B |
| August 26, 2026 | 2.772B |
| August 25, 2026 | 2.845B |
| August 24, 2026 | 2.892B |
| August 21, 2026 | 3.122B |
| August 20, 2026 | 2.706B |
| August 19, 2026 | 2.797B |
| August 18, 2026 | 2.645B |
| August 17, 2026 | 2.625B |
| August 14, 2026 | 2.581B |
| August 13, 2026 | 2.496B |
| August 12, 2026 | 2.377B |
| August 11, 2026 | 2.231B |
| August 10, 2026 | 2.229B |
| August 07, 2026 | 2.425B |
| August 06, 2026 | 2.362B |
| August 05, 2026 | 2.151B |
| August 04, 2026 | 2.142B |
| August 03, 2026 | 2.035B |
| July 31, 2026 | 1.815B |
| July 30, 2026 | 1.866B |
| July 29, 2026 | 1.831B |
| July 28, 2026 | 1.830B |
| July 27, 2026 | 1.965B |
| July 24, 2026 | 2.053B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 464.42B |
| Capricor Therapeutics, Inc. | 520.08M |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Incyte Corp. | 23.17B |
| Insmed, Inc. | 24.26B |
Market Cap Related Metrics
| Price to Book Value | 17.22 |
| Price | 11.74 |
| Earnings Yield | -1.81% |